Cathie Wood's position in Beam Therapeutics is currently worth $253 Million. That's 1.64% of their equity portfolio (17th largest holding). The investor owns 11.03% of the outstanding Beam Therapeutics stock. The first Beam Therapeutics trade was made in Q4 2020. Since then Cathie Wood bought shares eight more times and sold shares on three occasions. The investor's estimated purchase price is $676 Million, resulting in a loss of 63%.
Summary List Placement Cathie Wood''s Ark Invest ETFs surged on Monday following the landmark results of Intellia Therapeutics'' genomic editing clinical tri...Business Insider Markets, over 2 years ago